Gene · 481
Papers3,412
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 3,412
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pan-cancer analysis of cuproptosis regulation patterns and identification of mTOR-target responder in clear cell renal cell carcinoma. | Biol Direct | 2022 | 36209249 | PubTator, text mining | PubMed |
| GJB2 and GJB6 gene transcripts in the human cochlea: A study using RNAscope, confocal, and super-resolution structured illumination microscopy. | Front Mol Neurosci | 2022 | 36204137 | PubTator, text mining | PubMed |
| Comparison of multifidus degeneration between scoliosis and lumbar disc herniation. | BMC Musculoskelet Disord | 2022 | 36180878 | PubTator, text mining | PubMed |
| Polyphenols as Lung Cancer Chemopreventive Agents by Targeting microRNAs. | Molecules | 2022 | 36144639 | PubTator, text mining | PubMed |
| Could BMPs Therapy Be Improved if BMPs Were Used in Composition Acting during Bone Formation in Endochondral Ossification? | Int J Mol Sci | 2022 | 36142232 | PubTator, text mining | PubMed |
| The Role of miR-29s in Human Cancers-An Update. | Biomedicines | 2022 | 36140219 | PubTator, text mining | PubMed |
| The Prominent Role of miR-942 in Carcinogenesis of Tumors. | Adv Biomed Res | 2022 | 36133499 | PubTator, text mining | PubMed |
| Dermatologic Disease-Directed Targeted Therapy (D3T2): The Application of Biomarker-Based Precision Medicine for the Personalized Treatment of Skin Conditions-Precision Dermatology. | Dermatol Ther (Heidelb) | 2022 | 36121579 | PubTator, text mining | PubMed |
| High-throughput sequencing unravels the cell heterogeneity of cerebrospinal fluid in the bacterial meningitis of children. | Front Immunol | 2022 | 36119025 | PubTator, text mining | PubMed |
| ALS-linked loss of Cyclin-F function affects HSP90. | Life Sci Alliance | 2022 | 36114006 | PubTator, text mining | PubMed |
| Proteomic and functional characterization of intra-tumor heterogeneity in human endometrial cancer. | Cell Rep Med | 2022 | 36103879 | PubTator, text mining | PubMed |
| A case of multiple primary lung adenocarcinoma with a CD74-NRG1 fusion protein and HER2 mutation benefit from combined target therapy. | Thorac Cancer | 2022 | 36096509 | PubTator, text mining | PubMed |
| Integrating multi-omics summary data using a Mendelian randomization framework. | Brief Bioinform | 2022 | 36094096 | PubTator, text mining | PubMed |
| Therapeutic advances in metastatic pancreatic cancer: a focus on targeted therapies. | Ther Adv Med Oncol | 2022 | 36090800 | PubTator, text mining | PubMed |
| Na,K-ATPase Acts as a Beta-Amyloid Receptor Triggering Src Kinase Activation. | Cells | 2022 | 36078160 | PubTator, text mining | PubMed |
| miR-200c-3p, miR-222-5p, and miR-512-3p Constitute a Biomarker Signature of Sorafenib Effectiveness in Advanced Hepatocellular Carcinoma. | Cells | 2022 | 36078082 | PubTator, text mining | PubMed |
Dietary Epidermal Growth Factor Supplementation Alleviates Intestinal Injury in Piglets with Intrauterine Growth Retardation via Reducing Oxidative Stress and Enhancing Intestinal Glucose Transport and Barrier Function. | Animals (Basel) | 2022 | 36077965 | PubTator, text mining | PubMed |
| Comprehensive Analysis of Serum Small Extracellular Vesicles-Derived Coding and Non-Coding RNAs from Retinoblastoma Patients for Identifying Regulatory Interactions. | Cancers (Basel) | 2022 | 36077715 | PubTator, text mining | PubMed |
| ATP5B Is an Essential Factor for Hepatitis B Virus Entry. | Int J Mol Sci | 2022 | 36076968 | PubTator, text mining | PubMed |
| Structural basis for gating mechanism of the human sodium-potassium pump. | Nat Commun | 2022 | 36075933 | Swiss-Prot, curated | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/481/papers?page=16